MTOR and rheumatoid arthritis: Indeed, while our analysis examined mTOR and YAP pathways across the evolution of RA (arthralgia, UA, early, and established RA), an additional limitation of this work was the inability to examine patients in disease remission which would no doubt also provide a clearer picture on the role of mTOR in RA disease pathogenicity and synovial fibroblast activation.